Nationwide Idiopathic Subglottic Stenosis Evaluation

Summary

This study intends to determine how common idiopathic subglottic stenosis (iSGS) is across Canada, and to determine reasons why people develop the condition. The disease has increased from rare and newly described in the 1970s to a relatively common diagnosis in the last decade. The study investigators want to determine the incidence (number of new diagnoses per year) and prevalence (number of people living with the disease) in every province. This will help understand if there are certain areas with higher rates of disease and lead to new studies looking at factors causing the increased rate of disesae.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 100

Inclusion criteria:

All adults (18 years of age or older) previously diagnosed with idiopathic subglottic stenosis are eligible for this study.

Exclusion criteria:

You are not eligible to participate if you 1) Do not have subglottic stenosis. 2) Have subglottic stenosis caused by a known reason, for example autoimmune, prior surgery, prior intubation, congenital. 3) Have narrowing of the trachea below the subglottis. 4) Are less than 18 years of age.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

If you are eligible for this study, please contact the Principal Investigator Dr. Derrick Randall.

Principal investigator:

Derrick Randall

Clinical trial:

No

REB-ID:

REB22-1628